Literature DB >> 25193331

Age-dependent effect of obestatin on intestinal contractility in Wistar rats.

M Słupecka1, S G Pierzynowski2, A Kuwahara3, I Kato4, J Woliński5.   

Abstract

Obestatin is a 23-amino acid peptide encoded by the ghrelin gene. We have investigated the effect of obestatin on intestinal contractility in rats ranging from the suckling period till adolescence. Duodenal and middle jejunum whole-thickness preparations from neonatal and adult rats were studied in an organ bath, for isometric recording under treatment with obestatin (1μmolL(-1)) in the presence of acetylocholine (ACh), atropine and tetradotoxin (TTX). Both the EFS and ACh-stimulated contractile response, as well as spontaneous contractile activity is age-dependent and specific for the segment of jejunum. Except for the middle jejunum of 7day old rats, treatment with obestatin caused a significant TTX-sensitive increase in the amplitude of EFS-stimulated off-contraction of both intestinal segments studied. Following injection of obestatin, the amplitude of spontaneous contraction in the duodenum increased in 7day old rats. In the middle jejunum, treatment with obestatin significantly increased both the amplitude and frequency of spontaneous contraction in rats till the 28th day of life, whereas in adult rats the observed effect of obestatin was the opposite (P<0.001 and P<0.0001, respectively). The effects of treatment with obestatin on stimulation with increasing doses of ACh were only observed in the preparations from suckling rats. ACh-stimulated contractility in the duodenum was decreased while in the middle jejunum the observed effect was opposite. These results indicate the importance of peripheral obestatin in the cholinergic control of intestinal contractility in both neonatal and adult rats.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Contractility; Intestine; Neonates; Obestatin

Mesh:

Substances:

Year:  2014        PMID: 25193331     DOI: 10.1016/j.ygcen.2014.08.015

Source DB:  PubMed          Journal:  Gen Comp Endocrinol        ISSN: 0016-6480            Impact factor:   2.822


  3 in total

Review 1.  Obestatin as a key regulator of metabolism and cardiovascular function with emerging therapeutic potential for diabetes.

Authors:  Elaine Cowan; Kerry J Burch; Brian D Green; David J Grieve
Journal:  Br J Pharmacol       Date:  2016-05-27       Impact factor: 8.739

2.  Small intestinal development in suckling rats after enteral obestatin administration.

Authors:  Monika Słupecka-Ziemilska; Paulina Grzesiak; Michał Jank; Alicja Majewska; Agnieszka Rak; Paweł Kowalczyk; Ikuo Kato; Atsukazu Kuwahara; Jarosław Woliński
Journal:  PLoS One       Date:  2018-10-19       Impact factor: 3.240

3.  The effects of intra-stomach obestatin administration on intestinal contractility in neonatal piglets fed milk formula.

Authors:  Monika Słupecka-Ziemilska; Paulina Szczurek; Maria Boryczka; Małgorzata Gajewska; Piotr Wychowański; Atsukazu Kuwahara; Ikuo Kato; Żaneta Dzięgelewska; Jarosław Woliński
Journal:  PLoS One       Date:  2020-03-23       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.